Kindred Biosciences, Inc is a drug manufacturers-specialty & generic business based in the US. Kindred Biosciences shares (KIN) are listed on the NASDAQ and all prices are listed in US Dollars. Kindred Biosciences employs 63 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Kindred Biosciences
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KIN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Kindred Biosciences stock price (NASDAQ: KIN)Use our graph to track the performance of KIN stocks over time.
Kindred Biosciences shares at a glance
|Latest market close||$4.83|
|52-week range||$3.29 - $9.27|
|50-day moving average||$8.83|
|200-day moving average||$5.88|
|Wall St. target price||$10.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.63|
Buy Kindred Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Kindred Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Kindred Biosciences price performance over time
|1 week (2021-07-23)||N/A|
|1 month (2021-07-02)||-47.27%|
|3 months (2021-05-03)||-3.78%|
|6 months (2021-01-30)||N/A|
|1 year (2020-07-30)||N/A|
|2 years (2019-07-30)||N/A|
|3 years (2018-07-30)||N/A|
|5 years (2016-07-30)||N/A|
Kindred Biosciences financials
|Revenue TTM||$5.3 million|
|Gross profit TTM||$-1,162,000|
|Return on assets TTM||-26.44%|
|Return on equity TTM||-12.15%|
|Market capitalisation||$412.8 million|
TTM: trailing 12 months
Shorting Kindred Biosciences shares
There are currently 1.0 million Kindred Biosciences shares held short by investors – that's known as Kindred Biosciences's "short interest". This figure is 15.5% down from 1.2 million last month.
There are a few different ways that this level of interest in shorting Kindred Biosciences shares can be evaluated.
Kindred Biosciences's "short interest ratio" (SIR)
Kindred Biosciences's "short interest ratio" (SIR) is the quantity of Kindred Biosciences shares currently shorted divided by the average quantity of Kindred Biosciences shares traded daily (recently around 2.9 million). Kindred Biosciences's SIR currently stands at 0.35. In other words for every 100,000 Kindred Biosciences shares traded daily on the market, roughly 350 shares are currently held short.
However Kindred Biosciences's short interest can also be evaluated against the total number of Kindred Biosciences shares, or, against the total number of tradable Kindred Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kindred Biosciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Kindred Biosciences shares in existence, roughly 20 shares are currently held short) or 0.0377% of the tradable shares (for every 100,000 tradable Kindred Biosciences shares, roughly 38 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Kindred Biosciences.
Find out more about how you can short Kindred Biosciences stock.
Kindred Biosciences share dividends
We're not expecting Kindred Biosciences to pay a dividend over the next 12 months.
Kindred Biosciences share price volatility
Over the last 12 months, Kindred Biosciences's shares have ranged in value from as little as $3.29 up to $9.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kindred Biosciences's is 1.3232. This would suggest that Kindred Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Kindred Biosciences overview
Kindred Biosciences, Inc. , a commercial-stage biopharmaceutical company, engages in developing therapies for pets. Its product pipeline focuses on biologics for a range of indications primarily in dogs and cats. The company offers Mirataz, a mirtazapine transdermal ointment for the management of weight loss in cats; and Zimeta, a dipyrone injection for the control of fever in horses. It also develops KIND-016, a monoclonal antibody for the treatment of atopic dermatitis in dogs; KIND-032, a monoclonal antibody targeting interleukin-4 (IL-4) receptor for the treatment of atopic dermatitis in dogs; KIND-025 a canine fusion protein targeting IL-4 and IL-13 for atopic dermatitis in dogs; KIND-030, a monoclonal antibody targeting canine parvovirus for the prophylactic indication in dogs; KIND-509, an antibody for canine inflammatory bowel disease in dogs; KIND-510a, a long-acting feline recombinant erythropoietin being developed for the management of non-regenerative anemia in cats; and KIND-511, an anti-tumor necrosis factor treatment for newborn foals. The company was incorporated in 2012 and is headquartered in Burlingame, California. .
Stocks similar to Kindred Biosciences
Kindred Biosciences in the news
KIN Crosses Above Average Analyst Target
INVESTIGATION ALERT: Halper Sadeh LLP Investigates RFL, VNE, ACBI, KIN; Shareholders are Encouraged to Contact the Firm
Lifshitz Law Firm, P.C. Announces Investigation of BRBS, IRT, KIN, and MMAC
Frequently asked questionsWhat percentage of Kindred Biosciences is owned by insiders or institutions?
Currently 19.833% of Kindred Biosciences shares are held by insiders and 82.23% by institutions. How many people work for Kindred Biosciences?
Latest data suggests 63 work at Kindred Biosciences. When does the fiscal year end for Kindred Biosciences?
Kindred Biosciences's fiscal year ends in December. Where is Kindred Biosciences based?
Kindred Biosciences's address is: 1555 Bayshore Highway, Burlingame, CA, United States, 94010 What is Kindred Biosciences's ISIN number?
Kindred Biosciences's international securities identification number is: US4945771099 What is Kindred Biosciences's CUSIP number?
Kindred Biosciences's Committee on Uniform Securities Identification Procedures number is: 494577109
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert